Mode of action of streptomycin in relation to the changes in spinal fluid sugar in tuberculous meningitis.  I.  The role of streptomycin as a reducing agent and the specificity of the Shaffer-Hartmann method for determining true glucose when the antibiotic is used; in vitro experiments.
D000900:Anti-Bacterial Agents; D002555:Cerebrospinal Fluid; D005947:Glucose; D066298:In Vitro Techniques; D019163:Reducing Agents; D012680:Sensitivity and Specificity; D013307:Streptomycin / Q000627:therapeutic use*; D014376:Tuberculosis; D014390:Tuberculosis, Meningeal / Q000628:therapy*
D000900:Anti-Bacterial Agents; D019163:Reducing Agents; D005947:Glucose; D013307:Streptomycin
CEREBROSPINAL FLUID; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, MENINGEAL/therapy